RenovoRx Inc expected to post a loss of 30 cents a share - Earnings Preview

RenovoRx

27/02/2024 15:45

* RenovoRx Inc  RNXT.OQ   RNXT.O  is expected to show no
change in
quarterly revenue when it reports  results on February 29
(estimated) for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for RenovoRx Inc is for a
loss
of 30 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for RenovoRx
Inc is
$5.50​, above​ its last closing price of $1.37. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.30       -0.30      -0.13     Beat    56.7
 Jun. 30 2023  -0.25       -0.25      -0.31     Missed  -24
 Mar. 31 2023  -0.25       -0.25      -0.36     Missed  -44​
 Dec. 31 2022  -0.26       -0.26      -0.23     Beat    11.5
 ​​Sep.        -0.29       -0.29      -0.24     Beat    17.2
 30 2022                                                
 Jun. 30 2022  -0.28       -0.28      -0.29     Missed  -1.8​
 Mar. 31 2022  -0.21       -0.21      -0.33     Missed  -57.1
 Dec. 31 2021              -0.16      -0.12     Beat    25
 This summary was machine generated February 27 at 15:44 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)